These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18045069)

  • 1. Targeting angiogenesis in head and neck cancer.
    Saba NF; Shin DM; Khuri FR
    Curr Cancer Drug Targets; 2007 Nov; 7(7):643-9. PubMed ID: 18045069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis.
    Christopoulos A; Ahn SM; Klein JD; Kim S
    Head Neck; 2011 Aug; 33(8):1220-9. PubMed ID: 21755565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endostatin effective with head and neck cancers.
    J Am Dent Assoc; 2003 Oct; 134(10):1318, 1322. PubMed ID: 14620009
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
    Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
    Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting angiogenesis in head and neck cancer.
    Vassilakopoulou M; Psyrri A; Argiris A
    Oral Oncol; 2015 May; 51(5):409-15. PubMed ID: 25680863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting angiogenesis in head and neck cancer.
    Seiwert TY; Cohen EE
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.
    Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM
    Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer.
    Liu JF; Deng WW; Chen L; Li YC; Wu L; Ma SR; Zhang WF; Bu LL; Sun ZJ
    Mol Carcinog; 2018 Mar; 57(3):429-439. PubMed ID: 29215754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck.
    Katori H; Baba Y; Imagawa Y; Nishimura G; Kagesato Y; Takagi E; Ishii A; Yanoma S; Maekawa R; Yoshioka T; Nagashima Y; Kato Y; Tsukuda M
    Cancer Lett; 2002 Apr; 178(2):151-9. PubMed ID: 11867199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression.
    Chuang JY; Chen PC; Tsao CW; Chang AC; Lein MY; Lin CC; Wang SW; Lin CW; Tang CH
    Oncotarget; 2015 Feb; 6(6):4239-52. PubMed ID: 25738362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antivascular strategies--a new concept for diagnosis and therapy of head and neck cancer. A review].
    Dellian M; Eichhorn ME; Strieth S
    Laryngorhinootologie; 2002 Jul; 81(7):509-15. PubMed ID: 12173062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents.
    Lingen MW
    Crit Rev Oral Biol Med; 1999; 10(2):153-64. PubMed ID: 10759419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma.
    Jansen JF; Koutcher JA; Shukla-Dave A
    Angiogenesis; 2010 Jun; 13(2):149-60. PubMed ID: 20383743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the relationship between angiogenesis and cervical lymphatic metastasis in head and neck squamous cell carcinomas].
    Zheng H; Lin S
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):288-90. PubMed ID: 12916359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF inhibitors in brain tumors.
    Brastianos PK; Batchelor TT
    Clin Adv Hematol Oncol; 2009 Nov; 7(11):753-60, 768. PubMed ID: 20075834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Proton-Sensing G-Protein Coupled Receptor GPR4 Promotes Angiogenesis in Head and Neck Cancer.
    Jing Z; Xu H; Chen X; Zhong Q; Huang J; Zhang Y; Guo W; Yang Z; Ding S; Chen P; Huang Z
    PLoS One; 2016; 11(4):e0152789. PubMed ID: 27078157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma.
    Gallo O; Masini E; Bianchi B; Bruschini L; Paglierani M; Franchi A
    Hum Pathol; 2002 Jul; 33(7):708-14. PubMed ID: 12196922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.
    Saba NF; Vijayvargiya P; Vermorken JB; Rodrigo JP; Willems SM; Zidar N; de Bree R; Mäkitie A; Wolf GT; Argiris A; Teng Y; Ferlito A
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.
    Masuda M; Ruan HY; Ito A; Nakashima T; Toh S; Wakasaki T; Yasumatsu R; Kutratomi Y; Komune S; Weinstein IB
    Oral Oncol; 2007 Sep; 43(8):785-90. PubMed ID: 17169602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma.
    Liss C; Fekete MJ; Hasina R; Lingen MW
    Int J Cancer; 2002 Jul; 100(3):283-9. PubMed ID: 12115542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.